BRIEF published on 04/28/2026 at 22:20, 12 days 12 hours ago Le rapport financier 2025 de STEICO confirme les chiffres préliminaires Secteur De La Construction Proposition De Dividende Prévisions De Revenus Rapport Annuel 2025 Données Financières De STEICO
BRIEF published on 04/28/2026 at 22:05, 12 days 12 hours ago FORVIA Initiates Share Buyback Program Share Buyback Automotive Technology Market Confidence Forvia Performance Incentives
BRIEF published on 04/28/2026 at 22:05, 12 days 12 hours ago FORVIA lance un programme de rachat d'actions Rachat D'actions Technologie Automobile Confiance Du Marché Forvia Primes De Performance
BRIEF published on 04/28/2026 at 22:00, 12 days 12 hours ago Piramal Pharma Limited Reports FY26 Financial Results Strategic Investment Revenue Decline Segment Growth Piramal Pharma Limited Financial Results 2026
BRIEF published on 04/28/2026 at 22:00, 12 days 12 hours ago Piramal Pharma Limited publie ses résultats financiers pour l'exercice 2026 Investissement Stratégique Baisse Des Revenus Croissance Du Segment Piramal Pharma Limited Résultats Financiers 2026
BRIEF published on 04/28/2026 at 21:05, 12 days 13 hours ago VAT Group AG Shareholders Approve Board Proposals and 12% Dividend Increase Dividend Increase VAT Group AG Shareholder Resolutions Board Re-elections AGM 2026
BRIEF published on 04/28/2026 at 21:05, 12 days 13 hours ago Les actionnaires de VAT Group AG approuvent les propositions du conseil d'administration et une augmentation de 12 % du dividende. Réélections Du Conseil D'administration Résolutions Des Actionnaires Augmentation Des Dividendes Groupe TVA AG Assemblée Générale Annuelle 2026
BRIEF published on 04/28/2026 at 20:40, 12 days 14 hours ago GenSight Biologics annonce son Assemblée Générale Mixte de 2026 Actionnaires Assemblée Générale Documents Préparatoires Thérapie Génique GenSight Biologics
BRIEF published on 04/28/2026 at 20:40, 12 days 14 hours ago GenSight Biologics Schedules Annual General Meeting for May 2026 Annual General Meeting Regulatory Compliance Shareholder Information Investor Relations Gene Therapy
BRIEF published on 04/28/2026 at 20:40, 12 days 14 hours ago GenSight Biologics announces its 2026 Combined General Meeting Shareholders Gene Therapy General Assembly Preparatory Documents GenSight Biologics
Published on 05/11/2026 at 09:05, 1 hour 43 minutes ago Ameriwest Outlines Multiple Additional Breccia Pipe-Style Targets at Bornite from Historical Soil Sampling and Mapping
Published on 05/11/2026 at 08:05, 2 hours 43 minutes ago Tocvan Accelerates Gran Pilar: 5,000+ Meters Drilled to Date, Historic Workings Discovered on South Block, Pilot Progresses
Published on 05/09/2026 at 01:30, 2 days 9 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/11/2026 at 10:05, 43 minutes ago NOTAPE™ Tapeless & Seamless Zipper Pioneers Full-Lifecycle Green Innovation for Sustainable Manufacturing
Published on 05/11/2026 at 10:05, 43 minutes ago Newton Cinema Makes Cannes Market Debut and Announces Salim Ahamed's Fifth Directorial Feature
Published on 05/11/2026 at 10:05, 43 minutes ago VETRESKA Becomes Official Luxury Pet Accessories Partner of Formula 1 Driver Ollie Bearman
Published on 05/11/2026 at 10:00, 47 minutes ago Original-Research: Antimony Resources Corp. (von GBC AG): BUY
Published on 05/11/2026 at 09:16, 1 hour 32 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 28 avril 2026
Published on 05/07/2026 at 19:15, 3 days 15 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 15 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 3 days 15 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 3 days 15 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
